Intellia Therapeutics
NTLAIntellia Therapeutics is a biotechnology company developing biopharmaceuticals using a CRISPR gene editing system invented by Jennifer Doudna (with colleagues at University of California, Berkeley) and Virginijus Šikšnys (with colleagues at Vilnius University). The company has partnerships with Nova …
© Wikipedia /
Creative Commons CC-BY-SA 3.0 more at Wikipedia
Insider trades and stock quote 2024-2026
All insider trades at Intellia Therapeutics
Subscribe RSS| Date | Type | Insider | Position | Ø-Price | Volume |
|---|---|---|---|---|---|
| 7/22/2026 | Sell | Dulac, Edward J III. | EVP, Chief Financial Officer | $11.3 | $91,249 |
| 7/2/2026 | Sell | Dulac, Edward J III. | EVP, Chief Financial Officer | $18.0 | $84,186 |
| 7/1/2026 | Sell | Dube, Michael P. | VP, Chief Accounting Officer | $16.8 | $44,316 |
| 3/2/2026 | Sell | Clark, Eliana | EVP, Chief Technical Officer | $13.8 | $8,364 |
| 3/2/2026 | Sell | Basta, James | EVP, General Counsel | $13.8 | $16,688 |
All information without guarantee! No recommendation/consultation!
© U.S. Securities and Exchange Commission (SEC)